Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / *W EXP 12/31/202
-
Total 13F shares
-
3,501,852
-
Share change
-
+3,501,852
-
Total reported value
-
$5,656,000
-
Price per share
-
$1.60
-
Number of holders
-
21
-
Value change
-
+$5,656,000
-
Number of buys
-
21
Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q3 2021
As of 30 Sep 2021,
EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,501,852 shares.
The largest 10 holders included
ARISTEIA CAPITAL LLC, GOLDMAN SACHS GROUP INC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, MMCAP International Inc. SPC, CREDIT SUISSE AG/, Monashee Investment Management LLC, Blackstone Inc, CVI Holdings, LLC, WOLVERINE ASSET MANAGEMENT LLC, and Alpine Global Management, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.